ChapsVision, a leader in AI-based data processing, announced the acquisition of Sinequa – which is an AI-based enterprise search and Retrieval-Augmented Generation (RAG) company. And this strategic acquisition, combined with a new $90 million (€85 million) investment led by Tikehau Capital, Qualium Investissement, Bpifrance, GENEO Capital, and Jolt Capital, accelerates ChapsVision’s growth, strengthens its global presence, and expands technology capability.
ChapsVision utilizes AI and advanced data processing capabilities to empower businesses and public authorities in their digital transformation journeys. And its software suite is designed to harness diverse datasets, enabling organizations to unlock actionable insights and drive strategic decision-making. By optimizing the analysis and use of information, ChapsVision creates major value for its customers.
Sinequa is a leading vendor in the cognitive search and AI agents markets and serves prestigious clients like Pfizer, AstraZeneca, Airbus, TotalEnergies, Alstom, and NASA. By providing organizations with a powerful platform that leverages artificial intelligence and natural language processing, Sinequa makes data more accessible and actionable.
Through this deal, ChapsVision will enhance its ArgonOS platform, combining advanced search and data processing capabilities supporting clients’ digital excellence in manufacturing, life sciences, financial services, and aerospace and defense.
The acquisition aligns with ChapsVision’s ambitions for rapid international growth, particularly in Europe and North America. The recent funding round will further accelerate these efforts, expanding ChapsVision’s reach and investments in R&D and product enhancements.
The acquisition of Sinequa is financed with contributions in kind and by ChapsVision’s third round of financing of $90 million (€85 million). This funding will also enable ChapsVision to advance its international development. ChapsVision’s historical shareholders—Tikehau Capital, Bpifrance, Qualium Investissement, and GENEO Capital—along with Jolt Capital, a new investor, are financing this operation.
KEY QUOTES:
“We are delighted to welcome Sinequa to ChapsVision. Alexandre Bilger and his teams have developed a unique generative AI-augmented research technology, lauded by analysts and used by the world’s largest companies for the most demanding use cases. This technology is perfectly complementary to our ArgonOS platform and will allow us to market a unique offer in the massive processing of data. I would like to thank Jean Ferré, CEO of Sinequa, who successfully completed the company’s sales process and facilitated the smooth process.”
– Olivier Dellenbach, Founding CEO at ChapsVision
“Joining ChapsVision and becoming part of its strong growth represents a tremendous opportunity for Sinequa and our customers. Combining our expertise in AI and enterprise search with ChapsVision’s broad data intelligence portfolio creates unparalleled opportunities for clients of both companies to tackle the most complex data challenges with confidence.”
– Alexandre Bilger, Chief Architect Officer at Sinequa
